Moreover, it has been reported that luminal breast cancers (Luminal A, Luminal B, Triple negative/basal-like and HER2 type) are characterized by the expression of estrogen receptors [87], which are associated with a higher risk of local recurrence and metastasis [87,88]. This evidence concerns the gene ESR1 and breast carcinoma.